Status | Study |
Terminated |
Study Name: Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease Condition: Lesch-Nyhan Disease Self-injurious Behavior Date: 2012-12-14 Interventions: Drug: Ecopipam Antagonist of t |
Completed |
Study Name: Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease Condition: Lesch-Nyhan Disease Date: 2010-02-06 Interventions: Drug: Ecopipam Tablets, once daily, for two weeks up to 200 mg/day |
Withdrawn |
Study Name: Trial of Kuvan in Lesch-Nyhan Disease Condition: Behavioral Manifestations of Lesch-Nyhan Disease Date: 2009-07-08 Interventions: Drug: sapropterin oral 100mg tablets taken intact or dissolved in water or apple juice with morning meal |
Completed |
Study Name: Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease Condition: Lesch-Nyhan Syndrome Date: 1999-10-18 Interventions: Drug: aminomidazole carboxamide riboside |